valsartan has been researched along with Urinary Bladder Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huo, Q; Luan, T; Tang, Z; Wang, H; Wang, J; Yang, D | 1 |
1 other study(ies) available for valsartan and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Effects of Angiotensin Inhibitor Valsartan on the Expression of the Angiotensin II 1 Receptor, Matrix Metalloproteinases -2 and -9 in Human Bladder Cancer Cell Lines.
Topics: Angiotensin II Type 1 Receptor Blockers; Cell Line, Tumor; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Receptor, Angiotensin, Type 1; RNA, Messenger; Urinary Bladder Neoplasms; Valsartan | 2016 |